No Data
No Data
Earnings Flash (ELEV) ELEVATION ONCOLOGY Posts Q3 Loss $-0.22
Express News | Elevation Oncology- Sees to Initiate Dosing in Combination Portion of Phase 1 Trial of Eo-3021 in 4Q
Express News | Elevation Oncology-Sees Existing Cash, Cash Equivalents,Marketable Securities as of Sept 30 to Be Sufficient to Fund Current Operations Into 2026
Express News | Elevation Oncology Q3 Basic EPS USD -0.22
Express News | Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements
Press Release: Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements
No Data
No Data